Reporting Standards of GPP

Good publication practise can develop to ensure that pharmaceutical companies’ clinical trials are published responsibly and ethically.

The main Principle of Good Publication Practice is the design, and the results of all the trials should report in a perfect, precise, balanced, unambiguous, and timely manner. The guidelines on the GPP can evolve to give the editors and journals a framework to help them deal with the range of multiple ethical issues that arise in scientific publishing. The GPP guidelines canbe published originally in 2003 and have  updated twice, resulting in the current GPP3, which canbe published in 2015

The International Society is supporting the GPP guidelines for Medical Publication Professionals. It is mainly committed to encouraging medical research’s social and practical publication to inform the treatment decisions.

  • Reporting guidelines
  • Randomized trial
  • Observational studies
  • Systematic review and meta-analysis
  • Studies of diagnostic accuracy
  • Economic evaluations of health interventions
  • In case of studies, for completeness, reliability, and data collection, as well as data from the point of treatment code of ethics and position statement: the contribution of medical writers to scientific publications of Scholarly Work in Medical Journals
  • Code of ethics and position statement: the contribution of medical writers to scientific publications
  • Instructions for conducting clinical trials and communicating the outcomes of clinical trials.

References

  1. Bloomer, J. (2005). Developments in international financial reporting standards and other financial reporting issues. The Geneva Papers on Risk and Insurance-Issues and Practice, 30(1), 101-107.
  2. Rainville, A. (2017). Standards in green public procurement–A framework to enhance innovation. Journal of Cleaner Production, 167, 1029-1037.
  3. Rosenfield, P. (1975). GPP accounting relevance and interpretability. Journal of Accountancy (pre-1986), 140(000002), 52.